Capivasertib plus abiraterone in PTEN-deficient metastatic hormone-sensitive prostate cancer: CAPItello-281 phase III study. - Fizazi K; Clarke NW; De Santis M; Uemura H; Fay AP; Karadurmus N; Kwiatkowski M; Alvarez-Fernandez C; Jiang S; Sotelo M; Parslow D; Oliveira N; et al. (Annals of oncology : official journal of the European Society for Medical Oncology, 2026)